Abstract
Background Aneurysmal subarachnoid hemorrhage (aSAH) with World Federation of Neurological Societies (WFNS) grade V has a high mortality rate and poor prognosis. Some patients with WFNS grade V aSAH have had good outcomes after aggressive treatment; however, outcome predictions based on routine examinations and findings obtained at admission are yet to be reported. This study aimed to develop a decision tree model for predicting outcomes of patients with WFNS grade V aSAH to aid decision-making for treatment strategy.
Methods A multicenter study with retrospective and prospective data collected from 201 (derivation cohort) and 12 (validation cohort) patients with WFNS grade V aSAH, respectively, was conducted. Clinical outcomes were divided into good (Modified Rankin Scale [mRS] score at the time of discharge: 0–2) and poor (mRS score: 3–6) outcomes. A decision tree model was developed for the derivation cohort using the classification and regression tree method with clinical data including laboratory findings; it was named OPAS-V (Outcome Prediction in Aneurysmal Subarachnoid hemorrhage with WFNS grade V). The performance of the model was evaluated by area under the curve (AUC) and overall accuracy in both cohorts.
Results OPAS-V comprised 3 metrics; the percentage of lymphocytes (<49.9% or not), age (>50 yrs or not), and glucose to potassium ratio (≥3.2 or not). The model achieved an AUC of 0.828 (95% confidence interval: 0.712–0.944) and overall accuracy of 0.930. Moreover, the model performed well in the validation cohort with an AUC of 0.700 (95% confidence interval: 0.200–1) and overall accuracy of 0.833.
Conclusions This study developed the first decision tree model for predicting outcomes of patients with WFNS grade V aSAH, based on simple findings obtained at admission. This may aid clinicians in determining treatment strategies for severe conditions such as WFNS grade V aSAH.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This investigation was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI (grant number 21K09125)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Osaka University Clinical Research Review Committee approved the study (approval number 19486) and waived the need for additional written informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data referred to in the manuscript is available.
Non-standard Abbreviations and Acronyms
- aSAH
- aneurysmal subarachnoid hemorrhage
- AUC
- area under the curve
- CART
- classification and regression tree
- CRP
- C-reactive protein
- CT
- computed tomography
- CTA
- CT angiography
- EBI
- early brain injury
- ICH
- intracerebral hemorrhage
- IQR
- interquartile range
- mRS
- modified Rankin Scale
- NLR
- neutrophil to lymphocyte ratio
- OPAS-V
- Outcome Prediction in Aneurysmal Subarachnoid hemorrhage with WFNS grade V
- ROC
- receiver operating characteristic
- WFNS
- World Federation of Neurological Societies
